MAFLD - a new approach to fatty liver disease

Fatty liver disease associated with metabolic dysfunction (MAFLD) is a term introduced in 2020 to refer to fatty liver disease associated with systemic metabolic dysregulation. The name change from nonalcoholic fatty liver disease (NAFLD) to fatty liver disease associated with metabolic dysfunction...

Full description

Saved in:
Bibliographic Details
Main Authors: Borys Łozowski, Kinga Brzuszkiewcz-Łozowska, Monika Kułaga, Anna Kasprzak, Monika Grzybek, Diana Mazur-Lesińska, Barbara Szostak, Sylwia Wielgosz-Biała, Krzysztof Tyszkiewicz, Barbara Wilczyńska, Małgorzata Kasprzak
Format: Article
Language:English
Published: Kazimierz Wielki University 2025-05-01
Series:Journal of Education, Health and Sport
Subjects:
Online Access:https://apcz.umk.pl/JEHS/article/view/60039
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850190681126993920
author Borys Łozowski
Kinga Brzuszkiewcz-Łozowska
Monika Kułaga
Anna Kasprzak
Monika Grzybek
Diana Mazur-Lesińska
Barbara Szostak
Sylwia Wielgosz-Biała
Krzysztof Tyszkiewicz
Barbara Wilczyńska
Małgorzata Kasprzak
author_facet Borys Łozowski
Kinga Brzuszkiewcz-Łozowska
Monika Kułaga
Anna Kasprzak
Monika Grzybek
Diana Mazur-Lesińska
Barbara Szostak
Sylwia Wielgosz-Biała
Krzysztof Tyszkiewicz
Barbara Wilczyńska
Małgorzata Kasprzak
author_sort Borys Łozowski
collection DOAJ
description Fatty liver disease associated with metabolic dysfunction (MAFLD) is a term introduced in 2020 to refer to fatty liver disease associated with systemic metabolic dysregulation. The name change from nonalcoholic fatty liver disease (NAFLD) to fatty liver disease associated with metabolic dysfunction (MAFLD) was proposed to focus on the bidirectional interaction between fatty liver disease and metabolic changes and to emphasize the need to evaluate fatty liver disease independently of alcohol consumption and other comorbid causes of liver disease. Fatty liver disease associated with metabolic dysfunction (MAFLD) affects approximately 25% of the general population and more than 50% of patients with metabolic disorders. This new concept of MAFLD may have a broad impact on patients, physicians, healthcare professionals, and various stakeholders regarding fatty liver disease. In this way, MAFLD may influence clinical practice and increase awareness regarding fatty liver disease. This paper identifies differences between the MAFLD and NAFLD diagnoses, areas of benefit, potential limitations, and how the MAFLD terminology has opened up new areas of research.
format Article
id doaj-art-950d711cb0ec4e748512c39353c27205
institution OA Journals
issn 2391-8306
language English
publishDate 2025-05-01
publisher Kazimierz Wielki University
record_format Article
series Journal of Education, Health and Sport
spelling doaj-art-950d711cb0ec4e748512c39353c272052025-08-20T02:15:12ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062025-05-018010.12775/JEHS.2025.80.60039MAFLD - a new approach to fatty liver diseaseBorys Łozowski0https://orcid.org/0000-0002-1990-040XKinga Brzuszkiewcz-Łozowska1https://orcid.org/0000-0003-3941-027XMonika Kułaga2https://orcid.org/0009-0001-3949-2124Anna Kasprzak3https://orcid.org/0009-0002-1491-245XMonika Grzybekhttps://orcid.org/0009-0003-2246-800XDiana Mazur-Lesińska4https://orcid.org/0009-0000-2489-9100Barbara Szostak5https://orcid.org/0009-0000-8035-7584Sylwia Wielgosz-Biała6https://orcid.org/0009-0003-0567-5998Krzysztof Tyszkiewicz7https://orcid.org/0009-0005-0208-2286Barbara Wilczyńska8https://orcid.org/0009-0001-4939-7550Małgorzata Kasprzak9https://orcid.org/0009-0007-3791-1632Department of Gastroenterology, Independent Public Clinical Hospital No 4 in Lublin, Doktora Kazimierza Jaczewskiego 8, 20-954 LublinMedical University of Lublin, Doktora Kazimierza Jaczewskiego 8, 20-954 LublinStefan Cardinal Wyszyński Provincial Specialist Hospital SPZOZ in Lublin, al. Kraśnicka 100, 20-718 LublinStefan Cardinal Wyszyński Provincial Specialist Hospital SPZOZ in Lublin, al. Kraśnicka 100, 20-718 LublinStefan Cardinal Wyszyński Provincial Specialist Hospital SPZOZ in Lublin, al. Kraśnicka 100, 20-718 LublinStefan Cardinal Wyszyński Provincial Specialist Hospital SPZOZ in Lublin, al. Kraśnicka 100, 20-718 LublinStefan Cardinal Wyszyński Provincial Specialist Hospital SPZOZ in Lublin, al. Kraśnicka 100, 20-718 LublinStefan Cardinal Wyszyński Provincial Specialist Hospital SPZOZ in Lublin, al. Kraśnicka 100, 20-718 LublinUniversity Children's Hospital in Lublin, Profesora Antoniego Gębali 6, 20-093 LublinStefan Cardinal Wyszyński Provincial Specialist Hospital SPZOZ in Lublin, al. Kraśnicka 100, 20-718 Lublin Fatty liver disease associated with metabolic dysfunction (MAFLD) is a term introduced in 2020 to refer to fatty liver disease associated with systemic metabolic dysregulation. The name change from nonalcoholic fatty liver disease (NAFLD) to fatty liver disease associated with metabolic dysfunction (MAFLD) was proposed to focus on the bidirectional interaction between fatty liver disease and metabolic changes and to emphasize the need to evaluate fatty liver disease independently of alcohol consumption and other comorbid causes of liver disease. Fatty liver disease associated with metabolic dysfunction (MAFLD) affects approximately 25% of the general population and more than 50% of patients with metabolic disorders. This new concept of MAFLD may have a broad impact on patients, physicians, healthcare professionals, and various stakeholders regarding fatty liver disease. In this way, MAFLD may influence clinical practice and increase awareness regarding fatty liver disease. This paper identifies differences between the MAFLD and NAFLD diagnoses, areas of benefit, potential limitations, and how the MAFLD terminology has opened up new areas of research. https://apcz.umk.pl/JEHS/article/view/60039MAFLDNAFLDsteatohepatitisdiagnostic criteriaobesityliver diseases
spellingShingle Borys Łozowski
Kinga Brzuszkiewcz-Łozowska
Monika Kułaga
Anna Kasprzak
Monika Grzybek
Diana Mazur-Lesińska
Barbara Szostak
Sylwia Wielgosz-Biała
Krzysztof Tyszkiewicz
Barbara Wilczyńska
Małgorzata Kasprzak
MAFLD - a new approach to fatty liver disease
Journal of Education, Health and Sport
MAFLD
NAFLD
steatohepatitis
diagnostic criteria
obesity
liver diseases
title MAFLD - a new approach to fatty liver disease
title_full MAFLD - a new approach to fatty liver disease
title_fullStr MAFLD - a new approach to fatty liver disease
title_full_unstemmed MAFLD - a new approach to fatty liver disease
title_short MAFLD - a new approach to fatty liver disease
title_sort mafld a new approach to fatty liver disease
topic MAFLD
NAFLD
steatohepatitis
diagnostic criteria
obesity
liver diseases
url https://apcz.umk.pl/JEHS/article/view/60039
work_keys_str_mv AT borysłozowski mafldanewapproachtofattyliverdisease
AT kingabrzuszkiewczłozowska mafldanewapproachtofattyliverdisease
AT monikakułaga mafldanewapproachtofattyliverdisease
AT annakasprzak mafldanewapproachtofattyliverdisease
AT monikagrzybek mafldanewapproachtofattyliverdisease
AT dianamazurlesinska mafldanewapproachtofattyliverdisease
AT barbaraszostak mafldanewapproachtofattyliverdisease
AT sylwiawielgoszbiała mafldanewapproachtofattyliverdisease
AT krzysztoftyszkiewicz mafldanewapproachtofattyliverdisease
AT barbarawilczynska mafldanewapproachtofattyliverdisease
AT małgorzatakasprzak mafldanewapproachtofattyliverdisease